• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[17β-雌二醇对骨肉瘤MG63细胞中骨保护素、骨保护素配体及相关细胞因子表达的影响]

[The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells].

作者信息

Su Xin, Liao Er-yuan, Peng Jian, Wu Xian-ping

机构信息

Institute of Endocrinology & Metabolism, The Second Hospital of Xiangya Medical College, Central South University, Changsha 410011, China.

出版信息

Zhonghua Nei Ke Za Zhi. 2003 Nov;42(11):800-3.

PMID:14636471
Abstract

OBJECTIVE

To observe the regulative effects of 17 beta-estradiol (17 beta-E(2)) and ICI 182780 on the expression of osteoprotegerin (OPG), the ligand of osteoprotegerin (OPGL) and the related cytokines [macrophage colony-stimulating factor (M-CSF), TRAIL and transforming growth factor beta(TGF beta)] in MG63 cells.

METHODS

The expression of OPG, OPGL, M-CSF, TRAIL and TGF beta mRNA was examined by reverse transcriptase (RT)-PCR. The expression of OPG and OPGL protein was measured with Western blot.

RESULTS

(1) 17 beta-E(2) up-regulated the expression of OPG and TGF beta but down-regulated OPGL, M-CSF and TRAIL expression in MG63 cells. (2) ICI 182780 showed varied transactivating capability when regulating the expression of OPG, OPGL, TRAIL, M-CSF and TGF beta genes in MG63 cells.

CONCLUSIONS

(1) One of the key pathogenetic factors of postmenopausal osteoporosis is that estrogen deficiency leads to the decreasing expression of OPG and TGF beta but the increasing expression of some bone-resorbing cytokines such as OPGL, M-CSF and TRAIL in osteoblasts, then stimulation of osteoclast differentiation and activity which potentiates bone resorption and bone loss; (2) ICI 182780 shows partial transactivating activity in osteoblasts, so it should belong to a kind of selective estrogen receptor modulators.

摘要

目的

观察17β-雌二醇(17β-E₂)及ICI 182780对人骨肉瘤MG63细胞护骨素(OPG)、护骨素配体(OPGL)及相关细胞因子[巨噬细胞集落刺激因子(M-CSF)、肿瘤坏死因子相关凋亡诱导配体(TRAIL)和转化生长因子β(TGFβ)]表达的调控作用。

方法

采用逆转录聚合酶链反应(RT-PCR)检测OPG、OPGL、M-CSF、TRAIL及TGFβ mRNA的表达,蛋白质免疫印迹法检测OPG及OPGL蛋白表达。

结果

(1)17β-E₂上调MG63细胞OPG及TGFβ表达,下调OPGL、M-CSF及TRAIL表达。(2)ICI 182780在调控MG63细胞OPG、OPGL、TRAIL、M-CSF及TGFβ基因表达时表现出不同的反式激活能力。

结论

(1)绝经后骨质疏松症的关键发病因素之一是雌激素缺乏导致成骨细胞中OPG及TGFβ表达降低,而一些骨吸收相关细胞因子如OPGL、M-CSF及TRAIL表达增加,从而刺激破骨细胞分化及活性增强,促进骨吸收及骨质丢失;(2)ICI 182780在成骨细胞中表现出部分反式激活活性,应属于选择性雌激素受体调节剂。

相似文献

1
[The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells].[17β-雌二醇对骨肉瘤MG63细胞中骨保护素、骨保护素配体及相关细胞因子表达的影响]
Zhonghua Nei Ke Za Zhi. 2003 Nov;42(11):800-3.
2
[Effects of parathyroid hormone on osteoprotegerin expression and osteoprotegerin ligand and their related cytokines in human osteoblasts].甲状旁腺激素对人成骨细胞中骨保护素表达、骨保护素配体及其相关细胞因子的影响
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Oct;29(5):562-5.
3
Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.骨折愈合过程中骨保护素、核因子-κB受体激活剂配体(骨保护素配体)及相关促炎细胞因子的表达
J Bone Miner Res. 2001 Jun;16(6):1004-14. doi: 10.1359/jbmr.2001.16.6.1004.
4
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.成纤维细胞样基质细胞表达核因子κB受体活化因子配体并支持破骨细胞分化。
J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459.
5
Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.巨细胞瘤基质成分中破骨细胞分化信号的表达
J Bone Miner Res. 2000 Apr;15(4):640-9. doi: 10.1359/jbmr.2000.15.4.640.
6
Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.骨保护素是肿瘤坏死因子相关凋亡诱导配体/Apo2配体的可溶性诱饵受体,可作为人骨髓瘤细胞的旁分泌生存因子发挥作用。
Cancer Res. 2003 Mar 1;63(5):912-6.
7
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.骨保护素及骨保护素配体对人外周血单个核细胞前体形成破骨细胞的影响。
J Cell Biochem. 1999 Feb 1;72(2):251-61.
8
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.骨巨细胞瘤中骨保护素配体、骨保护素及核因子κB受体激活剂的基因表达:可能参与肿瘤细胞诱导的破骨样细胞形成。
Am J Pathol. 2000 Mar;156(3):761-7. doi: 10.1016/s0002-9440(10)64942-5.
9
Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.老年及去卵巢大鼠骨骼中核因子κB受体激活剂配体、核因子κB受体激活剂及骨保护素信使核糖核酸的表达谱
J Bone Miner Res. 2001 Aug;16(8):1416-25. doi: 10.1359/jbmr.2001.16.8.1416.
10
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.转化生长因子β通过直接和间接作用影响破骨细胞分化。
J Bone Miner Res. 2001 Oct;16(10):1787-94. doi: 10.1359/jbmr.2001.16.10.1787.

引用本文的文献

1
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.选择性雌激素受体调节剂(SERM)他莫昔芬、奥昔芬和雷洛昔芬对人破骨细胞的体外差异作用。
Br J Pharmacol. 2007 Jun;151(3):384-95. doi: 10.1038/sj.bjp.0707232. Epub 2007 Apr 10.